scispace - formally typeset
Open AccessJournal ArticleDOI

Role of Montelukast as Monotherapy in Improving Quality of Life of an Asthmatic Patient in Pakistan

Reads0
Chats0
TLDR
Montelukast has an effective role in asthma control as well as in improving the quality of life in the Pakistani population by comparing it with placebo.
Abstract
Introduction Uncontrolled and inadequately managed asthma substantially reduces Quality of Life (QOL) and can lead to premature death. The aim of this study is to understand the role of montelukast in improving quality of life in asthmatic patients by comparing it with placebo. Methods This prospective, single-arm, interventional study was conducted from September 2019 to February 2020 in the pulmonology outpatient department of a tertiary care hospital in Pakistan. All patients were prescribed montelukast (10 mg once daily). Results At day 28, participants had a higher score on the Asthma Quality of Life Questionnaire-Standard (AQLQ-S) overall and in all sub-domains compared to day 0. The improvement was significant overall and for the sub-domains of symptoms, activity limitations, and environmental stimuli. Conclusion Montelukast has an effective role in asthma control as well as in improving the quality of life in the Pakistani population.

read more

Content maybe subject to copyright    Report

Citations
More filters
Proceedings ArticleDOI

The CysLT1receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4in subjects with asthma

TL;DR: Montelukast profoundly inhibited the bronchoconstriction induced by inhaled LTE 4 in subjects with mild asthma, suggesting that the effects of LTE 4 on human airways are mediated solely by the CysLT 1 receptor.
References
More filters
Journal ArticleDOI

The global burden of asthma: executive summary of the GINA Dissemination Committee Report

TL;DR: This report provides a wealth of information that will be an invaluable source of information for those who wish to explore available data on the burden of asthma by region and will be extremely useful to develop background materials for World Asthma Day activities in 2004 and well into the future.
Journal ArticleDOI

Global asthma prevalence in adults: findings from the cross-sectional world health survey

TL;DR: This study provides a global estimate of the burden of asthma in adults, and suggests that asthma continues to be a major public health concern worldwide.
Journal ArticleDOI

Innate and adaptive immune responses in asthma

TL;DR: Recent advances in understanding of the sentinel role played by innate immunity provides new targets for disease prevention and treatment that include pathways of innate stimulation by environmental or endogenous pathogen-associated molecular patterns (PAMPs) and danger-associated Molecular patterns (DAMPs), and the identification of new T cell subsets and lymphoid cells.
Journal ArticleDOI

Validation of a Standardized Version of the Asthma Quality of Life Questionnaire

TL;DR: The AQLQ(S) has strong measurement properties and is valid for measuring health-related quality of life in asthma and the choice of instrument should depend on the task at hand.
Journal ArticleDOI

Efficacy and safety of montelukast in adults with asthma and allergic rhinitis

TL;DR: Montelukast 10mg is a safe and effective treatment for patients with both asthma and allergic rhinitis and overall QoL was "very good" or "good" in 85.2% of patients and a "strong" or 'marked' improvement in each of the four domains of sleep, work, everyday life and physical activity.
Related Papers (5)